May 20, 2021
Medicago, a Canadian subsidiary of Mitsubishi Tanabe Pharma, said on May 18 that its COVID-19 vaccine has delivered positive interim safety and immunogenicity data in the PII portion of its ongoing PII/III clinical trial. The PII part of the study...read more